Fernando de la Calle
PharmaMar, Spain
Biography
Fernando de la Calle is the Head of the Microbiology Department at Pharma Mar where he joined 30 years ago. He received his PhD in Molecular Biology from UAM (Madrid) in 1998. He also completed an Executive-MBA in 2005. He is a Co-author of the current hemisynthetic process for manufacturing the anticancer Yondelis®, the first European marine derived compound approved. He has been member of the International Advisory Group of ERA-MBT and BiodivERsA and Reviewer for H2020, FP7 and ERA-NET projects. He is the Scientific Contact Person from Pharma Mar for FP7/H2020 EU projects related to Marine Biodiversity and Biotechnology such as MAMBA, MaCuMBA, MicroB3 and INMARE.
Abstract
Abstract : Title: Marine microbiome and drug discovery